Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors

被引：11

作者：

Szabo, Monika ^{[1
]}

Lim, Herman D. ^{[1
]}

Herenbrink, Carmen Klein ^{[1
]}

Christopoulos, Arthur ^{[1
]}

Lane, J. Robert ^{[1
]}

Capuano, Ben ^{[1
]}

机构：

[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 03期

基金：

英国医学研究理事会;

关键词：

ALLOSTERIC MODULATORS; AGONIST; DRUGS; ANTIPSYCHOTICS; DISCOVERY; MODES; LEAD;

D O I：

10.1021/jm5013243

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Herein we describe the hybridization of a benzoxazinone M-1 scaffold with D-2 privileged structures derived from putative and clinically relevant antipsychotics to develop designed multiple ligands. The M-1 mAChR is an attractive target for the cognitive deficits in key CNS disorders. Moreover, activity at D-2 and 5-HT2A receptors has proven useful for antipsychotic efficacy. We identified 9 which retained functional activity at the target M-1 mAChR and D2R and demonstrated high affinity for the 5-HT2AR.

引用

页码：1550 / 1555

页数：6

共 50 条

[41] Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M1 Muscarinic Acetylcholine Receptors
van der Westhuizen, Emma T.
Spathis, Arthur
Khajehali, Elham
Jorg, Manuela
Mistry, Shailesh N.
Capuano, Ben
Tobin, Andrew B.
Sexton, Patrick M.
Scammells, Peter J.
Valant, Celine
Christopoulos, Arthur
MOLECULAR PHARMACOLOGY, 2018, 94 (01) : 770 - 783
[42] Antidepressant-like effect of aripiprazole via 5-HT1A, D1, and D2 receptors in the prefrontal cortex of olfactory bulbectomized mice
Takahashi, Kohei
Nakagawasai, Osamu
Nemoto, Wataru
Odaira, Takayo
Sakuma, Wakana
Tan-No, Koichi
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2018, 137 (03) : 241 - 247
[43] Molecular Pharmacology and Ligand Docking Studies Reveal a Single Amino Acid Difference between Mouse and Human Serotonin 5-HT2A Receptors That Impacts Behavioral Translation of Novel 4-Phenyl-2-dimethylaminotetralin Ligands
Canal, Clinton E.
Cordova-Sintjago, Tania
Liu, Yue
Kim, Myong S.
Morgan, Drake
Booth, Raymond G.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 347 (03) : 705 - 716
[44] SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile
Yves Claustre
Danielle De Peretti
Philippe Brun
Christiane Gueudet
Nathalie Allouard
Richard Alonso
Joëlle Lourdelet
André Oblin
Gabrielle Damoiseau
Dominique Françon
Marie-Françoise Suaud-Chagny
Régis Steinberg
Mireille Sevrin
Hans Schoemaker
Pascal George
Philippe Soubrié
Bernard Scatton
Neuropsychopharmacology, 2003, 28 : 2064 - 2076
[45] The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment Curacao extrapyramidal syndromes study IX
Wilffert, B.
Al Hadithy, A. F. Y.
Sing, V. J.
Matroos, G.
Hoek, H. W.
van Os, J.
Bruggeman, R.
Brouwers, J. R. B. J.
van Harten, P. N.
JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (06) : 652 - 659
[46] N-{[2-(4-Phenyl-piperazin-1-yl)-ethyl]-phenyl}-arylamides with Dopamine D2 and 5-Hydroxytryptamine 5HT1A Activity: Synthesis, Testing, and Molecular Modeling
Sukalovic, Vladimir
Bogdan, Anca Elena
Tovilovic, Gordana
Ignjatovic, Djurdjica
Andric, Deana
Kostic-Rajacic, Sladjana
Soskic, Vukic
ARCHIV DER PHARMAZIE, 2013, 346 (10) : 708 - 717
[47] SSR181507, a dopamine D2 receptor and 5-HT1A receptor ligand: Evidence for mixed anxiolytic- and antidepressant-like activities
Boulay, Denis
Depoortere, Ronan
Louis, Caroline
Lacave, Martine
Lucas, Marie Therese
Griebel, Guy
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 97 (03) : 428 - 435
[48] Identification of 2-fluoro-8-methyl-11-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-5 H-dibenzo[b,e][1,4]diazepine with clozapine-like mixed activities at muscarinic acetylcholine, dopamine, and serotonin receptors
Watanabe, Hitoshi
Ishida, Kyoji
Yamamoto, Masanori
Nakako, Tomokazu
Horiguchi, Masakuni
Isobe, Yoshiaki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 40
[49] SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity
Ronan Depoortere
Denis Boulay
Ghislaine Perrault
Olivier Bergis
Michel Decobert
Dominique Françon
Mireille Jung
Jacques Simiand
Philippe Soubrié
Bernard Scatton
Neuropsychopharmacology, 2003, 28 : 1889 - 1902
[50] Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase
Montastruc, Francois
Palmaro, Aurore
Bagheri, Haleh
Schmitt, Laurent
Montastruc, Jean-Louis
Lapeyre-Mestre, Maryse
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (10) : 1556 - 1565

← 1 2 3 4 5 →